维普中文期刊产品整合服务
217篇 您的检索式:作者名="Bachelot"
    题名 作者 年代 出处 被引量
1光纤聚合物探针在非均匀电磁场下的银纳米颗粒极化效应显示文摘介绍了光纤探针的制作流程及纳米颗粒的吸附方法,利用时域有限差分法对光纤探针的局域非均匀场下银纳米颗粒增强效应进行了数值模拟。首先,分析了不同形状的光纤聚合物探针尖端电场分布情况,为纳米颗粒的极化效应研究提供了参考;其次,模拟与仿真了纳米颗粒的半径、与探针间的距离对单个银纳米颗粒极化效应的影响;最后,以两个银纳米颗粒为例讨论了颗粒相对位置对极化效果的影响,并证明了光纤探针顶端以外的银纳米颗粒对电场的极化效应没有贡献。本文的仿真结果为光纤探针的制备以及其表面银纳米颗粒的吸附提供了理论支持。郑守国 李淼 张健 曾新华 Jerome Plain Renaud Bachelot 乔雷 2013发光学报2013,34,5:2
2Role of the P2Y12 genepolymorphism in platelet responsiveness to clopidogrel in healthy subjects显示文摘BURA A BACHELOT L OZA G 2006J Thromb Haemost2006,4,9:1
3IL-6 as an intracrine growth factor for renal carcinoma cell lines 显示文摘Alberti L Thomachot MC Bachelot T 2004Int J Cancer2004,111,5:1
4Resumption of ovarian function and pregnancies in 358 patients with premature ovarian failure显示文摘Bidet M Bachelot A Bissauge E 2011J Clin Endocrinol Metab2011,96,12:1
5Reproductive role of prolactin显示文摘Bachelot A Binart N 2007Reproduction2007,133,2:1
6Assessment of circulatingtumor cells and serum markers for progression-free survivalprediction in metastatic breast cancer: a prospective observationalstudy 显示文摘Bidard FC Hajage D Bachelot T 2012Breast Cancer Res2012,14,1:1
7Vinorelbine and Cisplatin(CIVIC regimen) for the treatment of metastatic breast carcinoma after failure of anthracycline and ( or ) paclitaxel-containing regimens 显示文摘Ray - Coquard I Biron P Bachelot T 1998Cancer1998,82,1:1
8Randomized phase Ⅱ trial of everolimus in combination with tamoxifen in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative metastatic breast cancer with prior exposure to aroma- tase inhibitors: a GINECO study显示文摘Bachelot T Bourgier C Cropet C 2012J Clin Oncol2012,30,22:1
9Randomized phase Ⅱtrial of everolimus in combination with tamoxifen in patients with hormone receptor-positive,human epidermal growth factor receptor 2negative metastatic breast cancer with prior exposure to aromatase inhibitors:a GINECO study显示文摘Bachelot T Bourgier C Cropet CA 2012J Clin Oncol2012,30,22:1
10Effects of deletion of the prolactin receptor on ovarian gene expression显示文摘Grosdemouge I Bachelot A Lucas A 2003Reprod Biol Endocrinol2003,1,:1
11Vinorelbine and cisplatin (CIVIC regiment)for the treatment of metastatic breast carcinoma after failure of anthracycline-and (or)paclitaxel-contaning regimens显示文摘 Biron P Bachelot T 2006Can-cer2006,92,:1
12Vinorelbine and cisplatin (CIVIC regimen)for the treatment of metastatic breast carcinoma after failure of anthracydine-and/or Paclitaxel-conraining regimens 显示文摘Ray-coquard I Biron P Bachelot T 1998Cancer1998,82,1:1
13Targeting EGFR with dovinib (TKI258) : preclinical and clinical data in breast cancer 显示文摘Andre F Bachelot T Campone M 2013Clin Cancer Res2013,19,13:1
14Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients显示文摘Bachelot T Ray-Coquard I Menetrier-Caux C 0,,11:1
15Continuous intravascular secretion of endostatin in mice from transduced hematopoietic stem cells显示文摘Pawliuk R Bachelot T Zurkiya O 2002Mol Ther2002,5,4:1
16Vinorelbine and cisplatin (CIVIC regimen) for the treatment of metastatic breast carcinoma after failure of anthracycline-and/or paclitaxel-containing regimen显示文摘Ray-Coquard I Biron P Bachelot T 1998Cancer1998,82,1:1
17Randomized phase II trial of everolimus in combination with tamoxifen in pa- tients with hormone receptor-positive, human epidermal growth factor receptor 2-negative metastatic breast cancer with prior expo- sure to aromatase inhibitors: a GINECO study显示文摘BACHELOT T BOURGIER C CROPET C 2012J Clin Oncol2012,30,22:1
18Randomized phase II trial of everolimus in combination with tamoxifen in pa- tients with hormone receptor-positive,human epidermal growth factor receptor 2-negative metastatic breast can- cer with prior exposure to aromatase inhibitors: a GINECO study 显示文摘Bachelot T Bourgier C Cropet C 2012J Clin Oncol2012,30,22:1
19Prognostic signif- icance of urokinase plasminogen activator and plasminogen activator inhibitor - 1 mRNA expression in lymph node - and hormone recep- tor -positive breast cancer显示文摘LEISSNER P VERJAT T BACHELOT T 2006BMC Cancer2006,6,:1
20Assessment of cireu lating tumor cells and serum markers for progression-free surviv al prediction in metastatic breast cancer= A prospective observa- tional study显示文摘Bidard FC Hajage D Bachelot T 2012Breast Cancer Res2012,14,1:1
返回顶部 每页显示:
共11页 首页 上一页 第1页 下一页 末页 /11 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费